Onconick | Empowering patients with next-gen ADC cancer treatment

Contact

Get in touch

office@onconick.com

Whether you have a question about our research, want to discuss a collaboration, or simply want to connect, we’d love to hear from you.

Daniel Krowarsch, PhD

daniel.krowarsch@onconick.com

Aleksandra Sokołowska-Wędzina, PhD

aleksandra.sokołowska-wedzina@onconick.com

Onconick sp. z o. o.
ul. Krzemowa 1
62-002 Złotniki, Poland

NIP: 9721306136
REGON: 385357821

About

Onconick specializes in precision oncology, developing new antibody-drug conjugates (ADCs) targeting highly specific novel markers in challenging cancer types.

Learn more

Contact

office@onconick.com

Onconick sp. z o.o.
ul. Krzemowa 1
62-002 Złotniki, Poland

Company

Legal

About

Onconick specializes in precision oncology, developing new antibody-drug conjugates (ADCs) targeting highly specific novel markers in challenging cancer types.

Learn more

Contact

office@onconick.com

Onconick sp. z o.o.
ul. Krzemowa 1
62-002 Złotniki, Poland

Company

Legal

About

Onconick specializes in precision oncology, developing new antibody-drug conjugates (ADCs) targeting highly specific novel markers in challenging cancer types.

Learn more

Contact

office@onconick.com

Onconick sp. z o.o.
ul. Krzemowa 1
62-002 Złotniki, Poland

Company

Legal